Pages that link to "Q36744247"

The following pages link to Initiation of adaptive immune responses by transcutaneous immunization (Q36744247):

Displaying 22 items.

• Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity (Q33614657) (← links)
• Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy (Q34009407) (← links)
• Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune response (Q34293564) (← links)
• Therapeutic Transcutaneous Immunization with a Band-Aid Vaccine Resolves Experimental Otitis Media (Q35901982) (← links)
• Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery (Q36331113) (← links)
• IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization (Q37275024) (← links)
• Peptide-based vaccines for cancer: realizing their potential (Q37340462) (← links)
• The possible role of isolated lymphoid follicles in colonic mucosal repair (Q37532129) (← links)
• Progress towards a needle-free hepatitis B vaccine (Q37810816) (← links)
• Targeting skin dendritic cells to improve intradermal vaccination. (Q37831193) (← links)
• Harnessing dendritic cells in inflammatory skin diseases. (Q37835969) (← links)
• Devices for intradermal vaccination (Q37958512) (← links)
• Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy (Q37999873) (← links)
• Transdermal immunization: biological framework and translational perspectives (Q38068975) (← links)
• A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens (Q39401464) (← links)
• Layer-by-layer-assembled multilayer films for transcutaneous drug and vaccine delivery (Q41877534) (← links)
• Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae (Q42061615) (← links)
• Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization (Q43243181) (← links)
• Vaccine delivery systems (Q49237143) (← links)
• Biofilm Biology and Vaccine Strategies for Otitis Media Due to Nontypeable Haemophilus influenzae (Q64448262) (← links)
• Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant (Q79905924) (← links)
• Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice (Q92496409) (← links)